A combination image shows an injection pen of Zepbound, eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters Teh appetite for blockbuster …
Tag:
Biotech and Pharmaceuticals
-
-
Trump Administration and AstraZeneca Discuss Cancer Treatment Collaboration Table of Contents Trump Administration and AstraZeneca Discuss Cancer Treatment Collaboration The Meeting and Key Discussion Points Focus on Immunotherapy Addressing Drug …
-
New recommendations last week from an influential vaccine panel handpicked by Health and Human services Secretary Robert F. Kennedy Jr. broke with long-standing U.S. precedent on Covid shots and childhood …
-
Members of the Advisory Committee on Immunization Practices listen to a presentation about Covid-19 during an ACIP meeting at the Centers for Disease Control and Prevention in Atlanta, Sept.19, 2025. …
-
CDC Director Susan Monarez fired After Refusal to Resign Table of Contents CDC Director Susan Monarez fired After Refusal to Resign Background on Susan Monarez and Her Nomination The Controversy …
-
HereS a list of the pharmaceutical companies mentioned in the text: Novartis (NVS) Novo Nordisk (NVO) Pfizer (PFE) Regeneron (REGN) * Sanofi (SNY) “`html Trump Demands 60-day Drug Price Cuts: …
-
Sweeping Healthcare Bill Faces Uphill Battle, Threatening Coverage for Millions A contentious healthcare proposal, dubbed the “big, lovely bill” by its proponents, recently passed the Senate and is now poised …
-
Shifting Sands: New Leadership at CDC Advisory Panel Signals Potential Vaccine Policy Changes Table of Contents Shifting Sands: New Leadership at CDC Advisory Panel Signals Potential Vaccine Policy Changes A …
-
CVS Health Posts Strong Q1 Results Amidst Insurance Turnaround and Legal Challenges Table of Contents CVS Health Posts Strong Q1 Results Amidst Insurance Turnaround and Legal Challenges CVS Health Reports …
-
Could Ozempic Hold the Key to Breaking the Chains of Alcohol Addiction? The FDA-approved drug Ozempic, initially designed to manage Type 2 diabetes, is making headlines for a compelling new …